Skip to main content
SpringerLink
Log in
Book cover

Diagnostische Hämatologie pp 391–439Cite as

M. Hodgkin

  • Chapter

  • 62 Accesses

Zusammenfassung

Pathohistologisch ist der M. Hodgkin (MH) durch große polyploide Zellen (Sternberg Reed = SR-Zellen) und ihre Vorstufen (Hodgkin-Zellen) charakterisiert. Im Tumorgewebe treten sie allerdings zahlenmäßig gegenüber Lymphozyten, Plasmazellen, Eosinophilen und Makrophagen meist weit zurück. Dieser zelluläre Hintergrund entspricht morphologisch reaktiven Zellen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aisenberg AC (1966) Immunologic status of Hodgkin’s disease. Cancer 19:385

    Google Scholar 

  2. Aisenberg AC (1991) Malignant Lymphoma. Lea and Febiger, Philadelphia

    Google Scholar 

  3. Aisenberg AC, Wikes BM (1982) Lymph node T cells in Hodgkin’s disease: analysis of suspensions with monoclonal antibody and rosetting techniques. Blood 51:522–527

    Google Scholar 

  4. Aisenberg AC, Kaplan MM, Rieder SV, Goldman JM (1970) Serum alkaline phosphatase at the onset of Hodgkin’s disease. Cancer 26:318

    PubMed  CAS  Google Scholar 

  5. Applefeld MM, Cole JF, Pollock SH, Sutton FJ, Slawson RG, Singleton RT, Wiernik PH (1981) The late appearance of chronic pericardial disease in patients treated by radiotherapy for Hodgkin’s disease. Ann Int Med 94:338–341

    PubMed  CAS  Google Scholar 

  6. Auclerc G, Auclerc MF, Weil M et al (1979) Features and prognosis of chemotherapy treated Hodgkin’s disease with initial bone marrow involvement. Cancer Chemother Pharmacol 2:189–196

    PubMed  CAS  Google Scholar 

  7. Bartl R, Frisch B, Burkhardt R (1984) Die Knochenmarksbiopsie. Eine neue Dimension für Klinik und Prognose maligner Bluterkrankungen. Basel: Karger

    Google Scholar 

  8. Bartl R, Frisch B, Burkhardt R, Huhn D, Pappenberger R (1982) Assessment of bone marrow histology in Hodgkin’s disease: correlation with clinical factors. Brit J Haematol 51:345–360

    CAS  Google Scholar 

  9. Bennet JM, Gralnick HR, De Vita VT (1968) Bone-marrow biopsy in Hodgkin’s disease. N Engl J Med 278:1179

    Google Scholar 

  10. Bennet MH, MacLennan KA, Easterling MJ, Vaughan Hudson B, Jelliffe AM, Vaughan Hudson G (1983) The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin’s disease: An analysis of 271 non-laparotomized cases (BNLI report no 22). Clin Radiol 34:497–501

    Google Scholar 

  11. Bennett MH, Mac Lennan KA, Vaughan-Hudson G et al (1991) Non Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: a 20 year experience. Ann Oncol 2:Suppl. 2, 83–92

    Google Scholar 

  12. Berkman AW, Woog JJ, Kickier TS, Ettinger DS (1983) Serial determination of antiplatelet antibodies in a patient with Hodgkin’s disease and autoimmune thrombocytopenia. Cancer 51:2057–2060

    PubMed  CAS  Google Scholar 

  13. Beverley PCL, Callard RE (1981) Distinctive functional characteristics of human “T” lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol 11:329–334

    CAS  Google Scholar 

  14. Blayney DW, Longo DL, Young RC, Greene MH, Hubbard SM, Postal MG, Duffey PL, DeVita VT (1987) Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease. N Engl J Med 316:710–714

    PubMed  CAS  Google Scholar 

  15. Bjoerkholm M, Holm G, Merk K (1982) Cyclic autoimmune hemolytic anemia as a presenting manifestation of splenic Hodgkin’s disease. Cancer 49:1702–1704

    Google Scholar 

  16. Boivin JF, O’Brien K (1988) Solid cancer risk after treatment of Hodkin’s disease. Cancer 61:2541–2546

    PubMed  CAS  Google Scholar 

  17. Bookman MA, Longo DL (1986) Concomitant illness in patients treated for Hodgkin’s disease. Cancer Treat Rev 13:77–111

    PubMed  CAS  Google Scholar 

  18. Bough-Grech A, Radford JA, Crowther D et al (1989) A comparative study of the nodular and diffuse variant of lymphocyte predominant Hodgkin’s disease. J Clin Oncol 7: 1303–1309

    Google Scholar 

  19. Breslau NA, McGuire JL, Zerwekh JE, Frenkel EP, Pak CYC (1984) Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 100:1–7

    PubMed  CAS  Google Scholar 

  20. Brown LR, Dreizen S, Daly TE, Drene FB, Handler S, Riggan U, Johnston DA (1978) Interrelations of oral microorganismus, immunoglobulins, and dental caries following radiotherapy. J Dental Research 57: 882

    CAS  Google Scholar 

  21. Brunning RD, Bloomfield CD, McKenna RW, Peterson L (1975) Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Int Med 82:365–366

    PubMed  CAS  Google Scholar 

  22. Buckner CD, RudolphRH, Feter A, Clift RA, Epstein RB, Funk DD, Neiman PE, Slichter SJ, Storb R, Thomas ED (1977) High-dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow. Cancer 29:357

    Google Scholar 

  23. Bucsky P (1987) Hodgkin’s disease: the Sternberg-Reed cell. Blut 55:413–420

    PubMed  CAS  Google Scholar 

  24. Bucsky P (1989) The Sternberg-Reed cell in Hodgkin’s disease - reply to a letter to the editor by H. Stein. Blut 58:89–92

    CAS  Google Scholar 

  25. Burns BF, Colby TV, Dorfman RF (1984) Differential diagnostic features of nodular L & H Hodgkin’s disease, including progressive transformation of germinal centers. Am J Surg Pathol 8:253–261

    PubMed  CAS  Google Scholar 

  26. Byhardt R, Brace K, Ruckdeschel J, Chang P, Martin R, Wiernik P (1975) Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin’s disease. Cancer 35:795–802

    PubMed  CAS  Google Scholar 

  27. Cabanillas F, Pathak S, Trujillo J et al (1988) Cytogenetic features of Hodgkin’s disease suggest possible origin from a lymphocyte. Blood 71: 1615–1617

    PubMed  CAS  Google Scholar 

  28. Callagher CJ et al (1984) The role of computed tomography in the detection of intrathoracic lymphoma. Br J Cancer 49:621

    Google Scholar 

  29. Carbone PP et al (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31: 1860

    PubMed  CAS  Google Scholar 

  30. Carde P, Burgers JMV, Henry-Amar M, Hayat M, Sizoo W, Van der Schueren E, Monconduit M, Noordijk EM, Lustman-Marechal J, Tanguy A, de Pauw B, Cosset JM, Cattan A, Schneider M, Thomas J, Meerwaldt JH, Somers R, Tubiana M (1988) Clinical stages I and II Hodgkin’s disease: a specifically tailored therapy according to prognostic factors. J Clin Oncol 6:239–252

    PubMed  CAS  Google Scholar 

  31. Carey RW, Linggood RM, Wood W, Blitzer PH (1984) Breast cancer developing in four women cured of Hodgkin’s disease. Cancer 54:2234–2236

    PubMed  CAS  Google Scholar 

  32. Carmel RJ, Kaplan HS (1976) Mantle irradiation in Hodgkin’s disease. Cancer 37:2813–2825

    PubMed  CAS  Google Scholar 

  33. Case DC Jr et al (1976) Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin’s disease. Cancer 38: 1807

    PubMed  CAS  Google Scholar 

  34. Castellino RA et al (1974) Lymphographic accuracy in Hodgkin’s disease and malignant lymphoma with a note on the “reactive” lymph node as a cause of most falsepositive Iymphograms. Invest Radiol 9: 155

    PubMed  CAS  Google Scholar 

  35. Castellino RA, Hoppe RT, Blank N, Young SW, Neumann C, Rosenberg SA, Kaplan HS (1984) Computed tomography, lymphography, and staging laparotomy: Correlations in initial staging of Hodgkin disease. Am J Radiol 143:37–41

    CAS  Google Scholar 

  36. Caya JG, Choi H, Tieu TM, Wollenberg NJ, Almagro VA (1984) Hodgkin’s disease followed by mycosis fungoides in the same patient. Case report and Literature review. Cancer 53:463–467

    Google Scholar 

  37. Cervantes F et al (1979) Eosinophilic meningitis in Hodgkin’s disease. Ann Intern Med 91:930

    PubMed  CAS  Google Scholar 

  38. Chapman RM et al (1979) Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet 1:285

    PubMed  CAS  Google Scholar 

  39. Cheng GK, Minden MD, Toyonaga B, Mak TW, McCulloch EA (1986) T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia. J Exp Med 163:414–424

    PubMed  CAS  Google Scholar 

  40. Chittal SM, Caveriviere P, Schwarting R, Gerdes J, Al Saati T, Rigal-Huguet F, Stein H, Delsol G (1988) Monoclonal antibodies in the diagnosis of Hodgkin’s disease. Am J Surg Pathol 12 (1):9–21

    PubMed  CAS  Google Scholar 

  41. Chu JY, McElfresh AE, Waeltermann RM (1976) Autoimmune hemolytic anemia as a presenting manifestation of Hodgkin’s disease. J Pediat 89:429

    PubMed  CAS  Google Scholar 

  42. Cimino G, Anselmo AP, DeLuca AM et al (1983) Bone marrow involvement at onset of Hodgkin’s disease. Tumori 69:47–51

    PubMed  CAS  Google Scholar 

  43. gestrichen

    Google Scholar 

  44. Coker DD, Morris DM, Coleman II, Schimpff SC, Wiemik PH, Elias EG (1983) Infection among 210 patients with surgically staged Hodgkin’s disease. Am J Med 75:97–109

    Google Scholar 

  45. Colby TV, Warnke RA (1980) The histology of the initial relapse of Hodgkin’s disease. Cancer 45:289–292

    PubMed  CAS  Google Scholar 

  46. Colby TV, Hoppe RT, Warnke RA (1982) Hodgkin’s disease: a clinicopathologic study of 659 cases. Cancer 49: 1848–1858

    PubMed  CAS  Google Scholar 

  47. Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS (1984) Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 53:878–883

    PubMed  CAS  Google Scholar 

  48. Crowther D, Fairley GH, Sewell RL (1967a) Lymphoid cells in Hodgkin’s disease. Nature 215: 1086

    PubMed  CAS  Google Scholar 

  49. Crowther D, Fairley GH, Sewell RL (1967b) Desoxyribonucleic acid synthesis in the lymphocytes of patients with malignant disease. Eur J Cancer 3:417

    PubMed  CAS  Google Scholar 

  50. Dalchau R, Kirkley J, Fabre JW (1980) Monoclonal antibody to a human leukocytespecific membrane glycoprotein probably homologous to the leukocyte-common (LC) antigen of the rat. Eur J Immunol 10:737–744

    PubMed  CAS  Google Scholar 

  51. DeLong ER et al (1984) Climate, socioeconomic status and Hodgkin’s disease mortality in the United States. J Chron Dis 37:209

    PubMed  CAS  Google Scholar 

  52. Deshazo RD, Ewel C, Londono S, Meetzger Z, Hoffeld JT, Oppenheim JJ (1981) Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin’s disease. Clin Exp Immunol 46:313–320

    PubMed  CAS  Google Scholar 

  53. De Vita VT Jr (1983) The relationship between tumor mass and resistance to chemotherapy: implications for surgical adjuvant treatment of cancer. Cancer 51: 1209–1220

    Google Scholar 

  54. Diehl V, Pfreundschuh M, Hauser FE, Loeffler M, Ruehl U, Bruecher H, Georgii A, Hiller E, Gerhartz H (1986) Zwischenergebnisse der Therapiestudien HD1, HD2 und HD3 der deutschen Hodgkin-Studiengruppe. Med Klin 81:1–6

    CAS  Google Scholar 

  55. Doerken H (1987) Zur Epidemiologie des Morbus Hodgkin: Das familäre Vorkommen. Med Klin 82:551–557

    Google Scholar 

  56. Doggett RS, Colby TV, Dorfman RF (1983) Interfollicular Hodgkin’s disease. Am J Surg Pathol 7: 145–149

    PubMed  CAS  Google Scholar 

  57. gestrichen

    Google Scholar 

  58. Donaldson SS (1978) Glatstein E, Vosti KL (1978) Bacterial infections in pediatric Hodgkin’s disease. Cancer 41:1949–1958

    PubMed  CAS  Google Scholar 

  59. Dorfman RF, Gatter KC, Pulford KAF, Mason DY (1986) An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin’s disease. Am J Pathol 123:508–519

    PubMed  CAS  Google Scholar 

  60. Dorreen MS, Habeshaw JA, Stansfeld AG, Wrigley PFM, Lister TA (1984) Characteristics of Sternberg-Reed, and related cells in Hodgkin’s disease: An immunohistological study. Brit J Cancer 49:465–476

    PubMed  CAS  Google Scholar 

  61. Dreizen S, Daly TE, Drane JB, Brown LR (1977) Oral complications of cancer radiotherapy. Postgraduate Medicine 61:85

    PubMed  CAS  Google Scholar 

  62. Durum, Oppenheim JJ (1985) Ann Rev Immunol 3:263

    CAS  Google Scholar 

  63. Ellis ME, Diehl LF, Granger E, Elson E (1989) Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol 30:115–120

    CAS  Google Scholar 

  64. Estevez ME, Ballart IJ, DeMacedo MP, Magnasco H, Nicastro MA, Sen L (1988) Dysfunction of monocytes in Hodgkin’s disease by excessive production of PGE-2 in long-term remission patients. Cancer 62:2128–2133

    PubMed  CAS  Google Scholar 

  65. Evans AS, Gutensohn NM (1984) A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin’s disease and their siblings. Int J Cancer 34:149–157

    PubMed  CAS  Google Scholar 

  66. Falini B, Stein H, Pileri S, Canino S, Farabbi R, Martelli MF, Grignani F, Fagioli M, Minelli O, Ciani C, Flenghi L (1987) Expression of lymphoid-associated antigens on Hodgkin’s and Reed-Sternberg cells of Hodgkin’s disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies. Histopathol 11: 1229–1242

    CAS  Google Scholar 

  67. Falk MH, Tesch H, Stein H, Diehl V, Jones DB, Fonatsch C, Bornkamm GW (1987) Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin’s disease. Int J Cancer 40:262–269

    PubMed  CAS  Google Scholar 

  68. Fisher RJ, DeVita VT, Bostick F, Vanhaelen C, Howser DM, Hubbard SM, Young RC (1980) Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin’s disease. Ann Int Med 92:595–599

    PubMed  CAS  Google Scholar 

  69. Fobair P et al (1986) Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol 4: 805

    PubMed  CAS  Google Scholar 

  70. Fonatsch C (1988) Cytogenetics of malignant lymphomas. Blut 57:101–109

    PubMed  CAS  Google Scholar 

  71. Ford RJ, Tsao J, Kouttab NM, Sahasrabuddhe CG, Mehta SR (1984) Association of an Interleukin abnormality with the T cell defect in Hodgkin’s disease. Blood 64:386–392

    PubMed  CAS  Google Scholar 

  72. Forni M, Hofman FM, Parker JW, Lukes RJ, Taylor CR (1985) B- and T-lymphocytes in Hodgkin’s disease: An immunohistochemical study using heterologous and monoclonal antibodies. Cancer 55: 728–737

    PubMed  CAS  Google Scholar 

  73. Friedman M et al (1976) Spinal cord compression in malignant lymphoma, Treatment and results. Cancer 37: 1485

    PubMed  CAS  Google Scholar 

  74. Gaertner HV, Wehrmann M, Inniger R, Steinke B (1987) Nodular sclerosing Hodgkin’s disease: prognostic relevance of morphological parameters. First International symposium on Hodgkin’s Lymphoma. Cologne Germany, Abstr:27

    Google Scholar 

  75. Gallagher CJ et al (1984) The role of computed tomography in the detection of intrathoracic lymphoma. Br J Cancer 49:621

    PubMed  CAS  Google Scholar 

  76. Garratty G et al (1974) Autoimmune hemolytic anemia in Hodgkin’s disease associated with an anti-Po Transfusion 14:226

    CAS  Google Scholar 

  77. Gattringer C, Greil R, Radaszkiewicz T, Huber H (1986) In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin’s disease: Quantity and quality of infiltration density depends on histopathological subtypes. Blut 53:49–58

    PubMed  CAS  Google Scholar 

  78. Georgii A, Vykoupil KF (1970) In: Musshoff K (ed) Diagnosis and Therapy of Malignant Lymphoma. Springer, Berlin

    Google Scholar 

  79. Glick JH (1988) Hodgkin’s disease. In: Cecil Textbook of Medicine. Saunders Philadelphia

    Google Scholar 

  80. Glick JH et al (1982) Treatment of advanced Hodgkin’s disease: 10-year experience in Eastern Cooperative Oncology Group. Cancer Treat Rep 66:855

    PubMed  CAS  Google Scholar 

  81. Gobbi PG, Cavalli C, Gendarini A, Crema A, Ricevuti G, Federico M, DiPrisco U, Ascari E (1985) Reevaluation of prognostic significance of symptoms in Hodgkin’s disease. Cancer 56:2874–2880

    PubMed  CAS  Google Scholar 

  82. Godde-Salz E et al (1982) Comparative Cytogenetic study of Hodgkin’s disease and Lymphogranulomatosis x (angio-immunoblastic lymphadenopathy). Cancer Treat Rep 66:1067

    Google Scholar 

  83. Golding B et al (1977) Production of leukocyte inhibitory factor (LIF) in Hodgkin’s disease: spontaneous production of an inhibitor of normal lymphocyte transformation. Clin Immunol Immunopathol 7:114

    PubMed  CAS  Google Scholar 

  84. Goodwin JS, Mesner RP, Barkhurst AD, Peake GT, Saiki JH, Williams RC (1977) Prostaglandin-producing suppressor cells in Hodgkin’s disease. N Engl J Med 297:963–968

    PubMed  CAS  Google Scholar 

  85. Gottdiener JS, Katin MJ, Borer JS, Bacharach SL, Green MV (1983) Late cardiac effects of therapeutic mediastinal irradiation. Asscessment by echocardiography and radionuclide angiography. N Engl J Med 308:569–572

    PubMed  CAS  Google Scholar 

  86. Gowitt GT, Chan WC, Brynes RK, Heffner LT (1985) T-cell lymphoma following Hodgkin’s disease. Cancer 56:1191–1196

    PubMed  CAS  Google Scholar 

  87. Greer JP, Kinney MC, Cousar JB, Flexner JM, Dupont WD, Graber SE, Greco FA, Collins RD, Stein RS (1986) Lymphocyte-depleted Hodgkin’s disease. Am J Med 81:209–214

    Google Scholar 

  88. Griesser H, Feller A, Lennert K, Minden M, Mak TW (1986a) Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disease. J Clin Invest 78: 1179

    PubMed  CAS  Google Scholar 

  89. Griesser H, Feller A, Lennert K, Tweedale M, Messner HA, Zalcberg J, Minden MD, Mak TW (1986b) The structure of the T cell gamma chain gene in lymphoproliferative disorders and lymphoma cell Jines. Blood 68:592–594

    PubMed  CAS  Google Scholar 

  90. Grufferman S, Cole P, Smith PG, Lukes RJ (1977) Hodgkin’s disease in siblings. N Engl J Med 296:248–250

    PubMed  CAS  Google Scholar 

  91. Guinee VF, Guido JJ, Pfalzgraf KA, Giacco GG, Lagarde C, Durand M, van der Veld en JW, Loewenberg B, Jereb B, Bretsky S, Meilof J, Hamersma EAM, Dische S, Anderson P (1985) The incidence of herpes zoster in patients with Hodgkin’s disease. Cancer 56:642–648

    PubMed  CAS  Google Scholar 

  92. Gutensohn M, Cole P (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304: 135–140

    PubMed  CAS  Google Scholar 

  93. Haas GS, Halperin E, Doseretz D, Linggood R, Russell PS, Colvin R, Barrett L, Cosimi AB (1984) Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin’s disease. J Immunol 132:1026–1030

    PubMed  CAS  Google Scholar 

  94. Hall PA, D’Ardenne AJ, Stansfeld AG (1988) Paraffin section immunohistochemistry. II. Hodgkin’s disease and large cell anaplastic (Ki1) lymphoma. Histopathol 13: 161–169

    CAS  Google Scholar 

  95. Halperin EC, Greenberg MS, Suit HD (1984) Sarcoma of bone and soft tissue following treatment of Hodgkin’s disease. Cancer 53:232–236

    PubMed  CAS  Google Scholar 

  96. Hanrock BW et al (1977) The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma. Clin Oncol 3: 137

    Google Scholar 

  97. Hansmann ML, Zwingers T, Boeske A, Loeffler H, Lennert K (1984) Clinical features of nodular paragranuloma (Hodgkin’s disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol 108:321–330

    PubMed  CAS  Google Scholar 

  98. Hansmann ML, Radzun HJ, Nebendahl C, Parwaresch MR (1988) Immunoelectronmicroscopic investigation of Hodgkin’s disease with monoclonal antibodies against histiocytes. Eur J Haematol 40:25–30

    PubMed  CAS  Google Scholar 

  99. Hart JS (1983) Chromosome abnormalities in human neoplasia. Cancer Treat Rev 10:173

    PubMed  CAS  Google Scholar 

  100. Haybittle JL, Easterling MJ, Bennett MH, Vaughan Hudson B, Hayhoe FGJ, Jelliffe AM, Vaughan Hudson G, MacLennan KA (1985) Review of british national lymphoma investigation studies of Hodgkin’s disease and development of prognostic index. Lancet 1:967–972

    PubMed  CAS  Google Scholar 

  101. Henry-Amar M, Somers R (1990) Survival outcome after Hodgkin’s Disease: a report from the international data base on Hodgkin’s disease. Semin Oncol 17:758–768

    PubMed  CAS  Google Scholar 

  102. Heyman MR, Walsh TJ (1987) Autoimmune neutropenia and Hodgkin’s disease. Cancer 59:1903–1905

    PubMed  CAS  Google Scholar 

  103. Holm G et al (1976) Lymphocyte abnormalities in untreated patients with Hodgkin’s disease. Cancer 37:751

    PubMed  CAS  Google Scholar 

  104. Honegger HP et al (1984) Was 1eisten Computertomographie und abdominale Ultraschalluntersuchung beim “staging” des Morbus Hodgkin? Schweiz Med Wochenschr 114:475

    PubMed  CAS  Google Scholar 

  105. Hosea SW, Brown EJ, Hamburger MI, Frank MM (1981) Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 304:245–250

    PubMed  CAS  Google Scholar 

  106. Hsu SM, Jaffe E (1984) Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin’s disease. Am J Clin Pat hoi 82:29–32

    CAS  Google Scholar 

  107. Hsu SM, Yang K, Jaffe ES (1985) Phenotypic expression of Hodgkin’s and ReedSternberg cells in Hodgkin’s disease. Am J Pathol 118:209–217

    PubMed  CAS  Google Scholar 

  108. Huber C, Huber H, Schmalzl F, Lederer B, Buetterich D, Braunsteiner H (1970) DNS-synthetisierende Biutlymphozyten beim malign en Lymphogranulom. Acta Haematol (Basel) 44:222

    CAS  Google Scholar 

  109. Huhn D et al (1973) Spezifische Hautveranderungen bei Morbus Hodgkin. Deutsch Med Wochenschr 98:2469

    CAS  Google Scholar 

  110. Hutchins MR, Slease RB, Murray JL, Gawith KE, Grozea PN (1985) Abnormal immunoregulation in remission Hodgkin disease. Am J Hematol 20: 119–128

    PubMed  CAS  Google Scholar 

  111. Jack AS, Cunningham D, Soukop M, Liddle CN, Lee FD (1986) Use of Leu M1 and anti epithelial membrane antigen monoclonal antibodies for diagnosting Hodgkin’s disease. J Clin Pathol 39:267–270

    PubMed  CAS  Google Scholar 

  112. Jacobson JO, Harris NL, Aisenberg AC (1988) Genomic analysis reliably distinguishes Hodgkin’s disease from peripheral T-cell lymphoma (Abstr). Lab Invest 58:250 A

    Google Scholar 

  113. Jacobson JO, Bringhurst FR, Harris NL, Weitzman SA, Aisenberg AC (1989) Humoral hypercalcemia in Hodgkin’s disease. Cancer 63:917–923

    PubMed  CAS  Google Scholar 

  114. Jacquillat C, Khayat D, Desprez-Curely JP, Weil M, Brocheriou C, Auclerc G, Chamseddine N, Bernard J (1984) Non-Hodgkin’s lymphoma occuring after Hodgkin’s disease. Four new cases and review of the Literature. Cancer 53:459–462

    PubMed  CAS  Google Scholar 

  115. Jandl JH (1987) Blood. Textbook of Hematology. Little, Brown and Company, Boston/Toronto

    Google Scholar 

  116. Joachim HL et al (1984) Hodgkin’s disease and the acquired immunodeficiency syndrome. Ann Intern Med 101:876

    Google Scholar 

  117. Jones SE (1980) Importance of staging in Hodgkin’s disease. Semin Oncol 7: 126

    PubMed  CAS  Google Scholar 

  118. Kadin ME (1982) Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rev 66:601

    CAS  Google Scholar 

  119. Kadin ME, Glatstein E, Dorfman RF (1971) Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin’s disease. Cancer 27: 1277–1294

    PubMed  CAS  Google Scholar 

  120. Kaldor JM, Day NE, Band P, Choi NW, Clarke EA, Coleman MP, Hakama M, Koch M, Langmark F, Neal FE, Pettersson F, Pompe-Kirn V, Prior P, Storm HH (1987) Second malignancies following testicular cancer, ovarian cancer and Hodgkin’s disease: an international collaborative study among cancer registries. Int J Cancer 39:571–585

    PubMed  CAS  Google Scholar 

  121. Kaldor JM, Day NE, Clarke EA et al (1990) Leukemia following Hodgkin’s disease. N Engl J Med 322:7–13

    PubMed  CAS  Google Scholar 

  122. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yam abe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T (1986) Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin’s disease. Blood 68:285–292

    PubMed  CAS  Google Scholar 

  123. Kant JA, Hubbard SM, Longo DL, Simon RM, DeVita VT Jr, Jaffe ES (1986) The pathologic and clinical heterogeneity of lymphocyte depleted Hodgkin’s disease. J Clin Oncol 4:284–294

    PubMed  CAS  Google Scholar 

  124. Kaplan HS (1980) Hodgkin’s disease, 2nd edn. Harvard University Press, Cambridge

    Google Scholar 

  125. Kaplan MM, Garnick MB, Gelber R, Li FP, Cassady JR, Sallan SE, Fine WE, Sack MJ (1983) Risk factors for thyroid abnormalities after neck irradiation for childhood cancer. Am J Med 74:272–280

    PubMed  CAS  Google Scholar 

  126. Kim HD, Bedetti CD, Boggs DR (1980) The development of non-Hodgkin’s lymphoma following therapy for Hodgkin’s disease. Cancer 46:2596–2602

    PubMed  CAS  Google Scholar 

  127. King GW, Grozea PC, Eyre HJ, LoBuglio AF (1979) Neoantigen response In patients successfully treated for lymphoma. Ann Int Med 90:892–895

    PubMed  CAS  Google Scholar 

  128. Knapp W et al (1989) Leucocyte Typing IV. Oxford University Press, Oxford

    Google Scholar 

  129. Knowles DM, Neri A, Pelicci PG, Burke JS, Wu A, Winberg CD, Sheibani K, Dalla-Favera R (1986) Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin’s disease: implications for lineage determination and differential diagnosis. Proc Natl Acad Sci USA 83:7942–7946

    PubMed  CAS  Google Scholar 

  130. Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS (1979) Occurrence of nonHodgkin’s lymphoma after therapy for Hodgkin’s disease. N Engl J Med 300:452–458

    PubMed  CAS  Google Scholar 

  131. Krikorian JG, Portlock CS, Rosenberg SA, Kaplan HS (1979) Hodgkin’s disease, stages I and II occurring below the diaphragm. Cancer 43: 1866–1871

    PubMed  CAS  Google Scholar 

  132. Kurtin PJ, Pinkus GS (1985) Leucocyte common antigen - a diagnostic discriminant between hematopoietic and non-hematopoietic neoplasms in paraffin sections using monoclonal antibodies: Correlation with immunologic studies and ultrastructural localization. Hum Pathol 16:353–365

    PubMed  CAS  Google Scholar 

  133. Lange B, Arbeter A, Hewetson J, Henle W (1978) Longitudinal study of EpsteinBarr virus antibody titers and excretion in pediatric patients with Hodgkin’s disease. Int J Cancer 22:521–527

    PubMed  CAS  Google Scholar 

  134. Lauria F, Foa R, Gobbi M, Camaschella C, Lusso P, Raspadori D, Tura S (1983) Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin’s disease in long-lasting remission. Cancer 52:1385–1388

    PubMed  CAS  Google Scholar 

  135. Lawler SD et al (1975) A comparison of cytogenetics and histopathology in malignant lymphomata. Br J Cancer 31:162

    Google Scholar 

  136. Lee FD (1987) Commentary: Hodgkin’s disease. Histopathol 11:1211–1217

    CAS  Google Scholar 

  137. Lehrich JR, Richardson EP Jr (1987) A 58-year-old man with a malignant thymoma and confusion. Case records of the Massachusetts General Hospital. Case 1: 1987. N Engl J Med 316:35

    Google Scholar 

  138. Leibenhaut MH, Hoppe RT, Efron B, Halpern J, Nelsen T, Rosenberg SA (1989) Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin’s disease. J Clin Oncol 7:81–91

    PubMed  CAS  Google Scholar 

  139. Lennert K, Mohri N (1974) Histologische Klassifizierung und Vorkommen des M. Hodgkin. Internist 15: 57–65

    CAS  Google Scholar 

  140. Lennert K, Mohri N (1978) Histopathology and diagnosis of Non-Hodgkin’s lymphoms. In: Lennert K (ed). Springer, Berlin Heidelberg New York, p 111

    Google Scholar 

  141. gestrichen

    Google Scholar 

  142. Leslie NT, Mauch PM, Hellman S (1985) Stage IA to IIB supradiaphragmatic Hodgkin’s disease. Cancer 55:2072–2078

    PubMed  CAS  Google Scholar 

  143. Levi JA, Wiernik PH (1977) Limited extranodal Hodgkin’s disease: unfavorable prognosis and therapeutic implications. Am J Med 63:365–372

    PubMed  CAS  Google Scholar 

  144. Levine AM, Thornton P, Forman SJ, Van Hale P, Holdorf D, Rouault CL, Poward D, Fernstein DI, Lukes RJ (1980) Positive Coombs test in Hodgkin’s disease. Significance and implication. Blood 55: 607–610

    PubMed  CAS  Google Scholar 

  145. Levy R, Kaplan HS (1974) Impaired lymphocyte function in untreated Hodgkin’s disease. N Engl J Med 290:181–186

    PubMed  CAS  Google Scholar 

  146. Lipa M, Kunynetz R, Pawlowski D, Kerbel G, Haberman H (1982) The occurrence of mycosis fungoides in two patients with preexisting Hodgkin’s disease. Arch Dermatol 118:563–567

    PubMed  CAS  Google Scholar 

  147. List AF, Doll DC, Greco FA (1985) Lung cancer in Hodgkin’s disease: Association with previous radiotherapy. J Clin Oncol 3:215–221

    PubMed  CAS  Google Scholar 

  148. List AF, Greer JP, Cousar JB, Stein RS, Flexner JM, Sinangil F, Davis J, Volsky DJ, Purtilo DT (1986) Non-Hodgkin’s lymphoma after treatment of Hodgkin’s disease: association with Epstein-Barr virus. Ann Intern Med 105: 668–673

    PubMed  CAS  Google Scholar 

  149. Loeffler M, Pfreundschuh M, Hasenclever D, Hiller E, Gerhartz H, Wilmanns W, Rohloff R, Ruehl U, Kuehn G, Fuchs R, Kirchner H, Teichmann J, Schoppe W, Petsch S, Wilhelmy W, Worst P, Pflueger KH, Hecht T, Bartels H, Gassmann W, Krueger G, Schmitz G, Oertel W, Diehl V (1988) Prognostic risk factors in advanced Hodgkin’s lymphoma. B1ut 56:273–281

    CAS  Google Scholar 

  150. Lukes RJ, Butler JJ, Hicks EB (1966) Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer 19:317–344

    Google Scholar 

  151. Lukes RJ, Tindle BH, Parker JW (1969) Reed-Sternberg-like cells in infectious mononucleosis. Lancet 2: 1003–1004

    PubMed  CAS  Google Scholar 

  152. Maggi E, Parronchi P, Macchia D, Bellesi G, Romagnani S (1988) High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin’s disease. Blood 71: 1503–1506

    PubMed  CAS  Google Scholar 

  153. Martin-Dupont P et al (1984) Anemie hemolytique auto-immune et maladie de Hodgkin. Sem Hop Paris 60:534

    PubMed  CAS  Google Scholar 

  154. Mason RS, Frankel T, Chan YL, Lissner D, Posen S (1984) Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med 100:59–61

    PubMed  CAS  Google Scholar 

  155. Mauch P, Hellman S (1984) Mediastinal Hodgkin’s disease. Significance of mediastinal involvement in early stage Hodgkin’s disease. Hematol Oncol 2:69

    PubMed  CAS  Google Scholar 

  156. Mauch P et al (1978) The significance of mediastinal involvement in early stage Hodgkin’s disease. Cancer 42:1039

    PubMed  CAS  Google Scholar 

  157. Medeiros LJ, Weiss LM, Warnke RA, Dorfman RF (1988) Utility of combining anti granulocyte with antileukocyte antibodies in differentiating Hodgkin’s disease from non-Hodgkin’s lymphoma. Cancer 62:2475–2481

    PubMed  CAS  Google Scholar 

  158. Meis JM, Osborne BM, Butler JJ (1986) A comparative marker study of large cell lymphoma, Hodgkin’s disease, and true histiocytic lymphoma in paraffin-embedded tissue. Am 1 Clin Pat hoi 86:591–599

    CAS  Google Scholar 

  159. Michlmayr G (1977) T-Lymphozyten und ihre Funktion beim M. Hodgkin. Wien Klin Wochenschr 89:3–15

    Google Scholar 

  160. Miettinen M, Franssila KO, Saxen E (1983) Hodgkin’s disease, lymphocytic predominance nodular. Cancer 51:2293–2300

    PubMed  CAS  Google Scholar 

  161. Moorthy AV et al (1976) Nephrotic syndrome in Hodgkin’s disease. Evidence for pathogenesis alternative to immune complex deposition. Am J Med 61:471

    PubMed  CAS  Google Scholar 

  162. Morgan GW et al (1985) Late cardiac, thyroid and pulmonary sequelase of mantle radiotherapy for Hodgkin’s disease. Int J Radiat Oncol Bioi Phys 11: 1925

    CAS  Google Scholar 

  163. Mori N, Oka K, Skuma H, Tsunoda R, Kojima M (1985) Immunoelectron microscopic study of Hodgkin’s disease. Cancer 56:2605–2611

    PubMed  CAS  Google Scholar 

  164. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J (1989) Hodgkin’s disease and Epstein-Barr virus: Altered antibody pattern before diagnosis. N Engl J Med 320:689:695

    Google Scholar 

  165. Mundy GR, Ibbotson KJ, D’Souza SM (1985) Tumor products and the hypercalcemia of malignancy. J Clin Invest 76:391–394

    PubMed  CAS  Google Scholar 

  166. Musshoff K (1971) Prognostic and therapeutic implications of staging in extranodal Hodgkin’s disease. Cancer Res 31:1814–1827

    PubMed  CAS  Google Scholar 

  167. Neiman RS, Rosen PJ, Lukes RJ (1973) Lymphocyte-depletion Hodgkin’s disease: a clinicopathological entity. N Engl J Med 288:751–754

    PubMed  CAS  Google Scholar 

  168. Neta R, Oppenheim JJ (1988) Why should internists be interested in Interleukin-1? Ann Int Med 109: 1–2

    PubMed  CAS  Google Scholar 

  169. Nordenstoft AM et al (1984) Experiences from the national Danish Hodgkin’s study group (L YGRA) with respect to diagnosis, classification and treatment of Hodgkin’s disease. Acta Radiol Oncol 23: 163

    Google Scholar 

  170. Norton AJ, Isaacson PG (1985) Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin’s disease. J Clin Pathol 38:1241–1246

    PubMed  CAS  Google Scholar 

  171. Notter DT, Grossman PL, Rosenberg SA, Remington JS (1980) Infections in patients with Hodgkin’s disease: a clinical study of 300 consecutive adult patients. Rev Infect Dis 2:761–800

    PubMed  CAS  Google Scholar 

  172. O’Connor NTJ, Crick JA, Gatter KC, Mason DY, Falini B, Stein HS (1987) Cell lineage in Hodgkin’s disease. Lancet 1: 158

    PubMed  Google Scholar 

  173. Oliviero S, Cortese R (1989) The human haptoglobin gene promotor: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. EMBO J 8:1145–1151

    PubMed  CAS  Google Scholar 

  174. Pedersen-Bjergaard J, Philip P (1987) Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, pre leukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases. Brit J Haematol 66:199–207

    CAS  Google Scholar 

  175. Pedersen-Bjergaard J, Larsen SO, Struck J, Hansen HH, Specht L, Ersboll J, Hansen MM, Nissen NI (1987) Risk of therapy-related leukaemia and preleukaemia after Hodgkin’s disease. Lancet 2:83–88

    PubMed  CAS  Google Scholar 

  176. Pinkus GS, Said JW (1985) Hodgkin’s disease, lymphocyte predominance type, nodular - a distinct entity? Am J Pathol 118: 1–6

    PubMed  CAS  Google Scholar 

  177. Pinkus GS, Thomas P, Said JW (1985) Leu-M1 - a marker for Reed-Sternberg cells in Hodgkin’s disease. Am J Pathol 119:244–252

    PubMed  CAS  Google Scholar 

  178. Poppema S (1980) The diversity of the immunohistological staining pattern of Sternberg-Reed cells. J Histochem Cytochem 28:788–791

    PubMed  CAS  Google Scholar 

  179. Poppema S, Kaiserling E, Lennert K (1979a) Nodular paragranuloma and progressively transformed germinal centers: Ultrastructural and immunohistologic findings. Virch Arch B Cell Pathol 31:211–225

    CAS  Google Scholar 

  180. Poppema S, Kaiserling E, Lennert K (1979b) Hodgkin’s disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centers - a cytohistological study. Histopathol 3:295–308

    CAS  Google Scholar 

  181. Poppema S, Bhan AK, Reinherz EL, Posner MR, Schlossman SF (1982) In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin’s disease. Blood 59:226–232

    PubMed  CAS  Google Scholar 

  182. Posner MR, Reinherz E, Lane H, Mauch P, Hellman S, Schlossman SF (1983) Circulating lymphocyte populations in Hodgkin’s disease after mantle and paraaortic irradiation. Blood 61:705–708

    PubMed  CAS  Google Scholar 

  183. Raab-Traub N, Flynn K (1986) The structure of the terminal of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889

    PubMed  CAS  Google Scholar 

  184. Razis DV, Diamond HD, Craver LF (1959) Familial Hodgkin’s disease. Its significance and implications. Ann Int Med 51:933–971

    PubMed  CAS  Google Scholar 

  185. Reboul F et al (1978) Herpes zoster and varicella infections in children with Hodgkin’s disease. An analysis of contributing factors. Cancer 41: 95

    PubMed  CAS  Google Scholar 

  186. Regula DP, Hoppe RT, Weiss LM (1988) Nodular and diffuse types of lymphocyte predominance Hodgkin’s disease. N Engl J Med 318:214–219

    PubMed  Google Scholar 

  187. Robert NJ, Schneiderman H (1984) Hodgkin’s disease and the acquired immunodeficiency syndrome. Ann Intern Med 101:142

    PubMed  CAS  Google Scholar 

  188. Robertson SJ, Lowman JT, Grufferman S, Kostyu D, van der Horst CM, Matthews TJ, Borowitz MJ, Bigner SH (1987) Familial Hodgkin’s disease: A clinical and laboratory investigation. Cancer 59:1314–1319

    PubMed  CAS  Google Scholar 

  189. Romagnani S, Almerigogna F, Giudizi MG, Biagiotti R, Centis D, Alessi A, Ricci M, Tosi R (1985) Anti-Ia reactivity in sera of untreated patients with active Hodgkin’s disease. Clin Immunol Immunopathol 34: 1–10

    PubMed  CAS  Google Scholar 

  190. Romagnani S, Maggi E, Parronchi P, Macchia D, Del Prete GF, Rossi-Ferrini PL, Ricci M, Moretta L (1986) Clonal analysis of T lymphocytes in spleens from patients with Hodgkin’s disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of Interleukin-2. Int J Cancer 37:343–349

    PubMed  CAS  Google Scholar 

  191. Rosenberg SA (1971) Hodgkin’s disease of the bone marrow. Cancer Res 31: 1733–1736

    PubMed  CAS  Google Scholar 

  192. Rosenberg SA (1988) Exploratory laparotomy and splenectomy for Hodgkin’s disease: a commentary. J Clin Oncol 6:574–575

    PubMed  CAS  Google Scholar 

  193. Rosenberg SA, Kaplan HS (1985) The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin’s disease: 1962–1984. Int J Radiat Oncol Biol Phys 11:5–22

    PubMed  CAS  Google Scholar 

  194. Rosenberg SA (1991) The continuing challenge of Hodgkin’s disease. Ann Oncol 2:Suppl. 2:29–31

    Google Scholar 

  195. Rosner F, Zarrabi MH (1983) Late infections following splenectomy in Hodgkin’s disease. Cancer Invest 1: 57

    PubMed  CAS  Google Scholar 

  196. Rostock RA et al (1983) Thoracic CT scanning for mediastinal Hodgkin’s disease results and therapeutic implications. Int J Radiat Oneol Biol Phys 9: 1451

    CAS  Google Scholar 

  197. Rowley JD (1982) Chromosomes in Hodgkin’s disease. Cancer Treat Rep 66:639

    PubMed  CAS  Google Scholar 

  198. Rowley JD et al (1981) Nonrandom chromosome abnormalities in acute and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 58:759

    PubMed  CAS  Google Scholar 

  199. Ruckdeschel (1975) Med 54:245

    CAS  Google Scholar 

  200. Sacks EL, Donaldson SS, Gordon J, Dorfman RF (1978) Epitheloid granulomas associated with Hodgkin’s disease. Clinical correlations in previously untreated patients. Cancer 41: 562–567

    PubMed  CAS  Google Scholar 

  201. Sapozink MD, Kaplan HS (1983) Intracranial Hodgkin’s disease. A report of 12 cases and review of the literature. Cancer 52: 1301

    PubMed  CAS  Google Scholar 

  202. Schaadt M, Diehl V (1991) Hodgkin Lymphome (Lymphogranulomatose). In: Innere Medizin, (Classen M, Diehl V, Kochsiek K, Hrsg.), Urban und Schwarzenberg, München

    Google Scholar 

  203. Schaefer K, Saupe J, Pauls A, von Herrath D (1986) Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with Hodgkin’s lymphoma. Klin Wochenschr 64:89–91

    PubMed  CAS  Google Scholar 

  204. Schellong G, Waubke-Landwehr AK, Langermann HJ, Riehm HJ, Braemswig J, Ritter J (1986) Prediction of splenic involvement in children with Hodgkin’s disease. Cancer 57:2049–2056

    PubMed  CAS  Google Scholar 

  205. Schilsky RL et al (1981) Long-term follow-up of ovarians failure in women with Hodgkin’s disease. 1. Hormone function. JAMA 242: 1877

    Google Scholar 

  206. Schimpff SC, Diggs CH, Wiswell JG, Salvatore PC, Wiernik PH (1980) Radiationrelated thyroid dysfunction: implications for the treatment of Hodgkin’s disease. Ann Int Med 92:91–98

    PubMed  CAS  Google Scholar 

  207. Sherrod AE, Felder B, Levy N, Epstein A, Marder R, Lukes RJ, Taylor CR (1986) Immunohistologic identification of phenotypic antigens associated with Hodgkinand Reed-Sternberg cells. Cancer 57:2135–2140

    PubMed  CAS  Google Scholar 

  208. Shimm DS, Linggood RM, Weitzman SA (1983) Overwhelming post-splenectomy infection in Hodgkin’s disease: pathogenesis and prevention. Clin Radiol 34:95

    PubMed  CAS  Google Scholar 

  209. Silverman CL et al. (1982) Cutaneous Hodgkin’s disease. Arch Dermat 118:918

    CAS  Google Scholar 

  210. Smith JL, Butler JJ (1980) Skin involvement in Hodgkin’s disease. Cancer 45:354

    PubMed  Google Scholar 

  211. Souham RL et al (1983) Defective in vitro antibody production to varicella zoster and other virus antigens in patients with Hodgkin’s disease. Clin Exp Immuno1 53:297

    Google Scholar 

  212. Soulilou JP et al (1985) Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin’s disease. Eur J Cancer Clin Onco1 21:935

    Google Scholar 

  213. Stein H (1988) Comments on Hodgkin’s disease: the Sternberg-Reed cell by P. Bucsky. Blut 57:143–146

    CAS  Google Scholar 

  214. Stein H, Uchanska-Ziegler B, Gerdes J, Ziegler A, Wernet P (1982) Hodgkin and Sternberg-Reed cells contain antigens specific to late cells of granulopoiesis. Int J Cancer 29:283–290

    PubMed  CAS  Google Scholar 

  215. Stein H, Mason DY, Gerdes J, O’Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K (1985) The expression of the Hodgkin’s disease associated antigen Ki-l in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848–858

    PubMed  CAS  Google Scholar 

  216. Stein H, Hansmann ML, Lennert K, Brandtzaeg P, Gatter KC, Mason DY (1986) Reed-Sternberg and Hodgkin cells in lymphocyte-redominant Hodgkin’s disease of nodular subtype contain J chain. Am J Clin Pathol 86:292–297

    PubMed  CAS  Google Scholar 

  217. Stein H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F, Kratzsch H (1991): The nature of Hodgkin- and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann Oncol 2:Suppl. 2:33–38

    Google Scholar 

  218. Strauchen JA (1984) Lectin receptors as markers of lymphoid cells. II. ReedSternberg cells share Lectin-binding properties of monocyte macrophages. Am J Pathol 116:370–376

    PubMed  CAS  Google Scholar 

  219. Strayer DR, Bender RA (1977) Eosinophilic meningitis complicating Hodgkin’s disease: a report of a case and review of the literature. Cancer 40:406

    PubMed  CAS  Google Scholar 

  220. Strum SB, Rappaport H (1971) Interrelations of the histologic types of Hodgkin’s disease. Arch Pathol 91: 127–134

    PubMed  CAS  Google Scholar 

  221. Sullivan JL, Ochs HD, Schiffman G, Hammerschlag MR, Miser J, Vichinsky E, Wedgwood RJ (1978) Immune response after splenectomy. Lancet i:178

    Google Scholar 

  222. Sundeen J, Lipford E, Uppenkamp M, Sussman E, Wahl L, Raffeld M, Cossman J (1987) Rearranged antigen receptor genes in Hodgkin’s disease. Blood 70:96–103

    PubMed  CAS  Google Scholar 

  223. Szur L et al (1970) Primary cutaneous Hodgkin’s disease. Lancet 1:1016

    PubMed  CAS  Google Scholar 

  224. Thar TL et al (1979) Hodgkin’s disease, stages I and II. Relationship of recurrence to site of disease, radiation dose, and number of sites involved. Cancer 43: 1101

    PubMed  CAS  Google Scholar 

  225. Timens W, Visser L, Poppema S (1986) Nodular lymphocyte predominance type of Hodgkin’s disease is a germinal center lymphoma. Lab Invest 54:457–461

    PubMed  CAS  Google Scholar 

  226. Trudel MA, Krikorian JG, Neiman RS (1987) Lymphocyte predominance Hodgkin’s disease: A clinicopathologic reassessment. Cancer 59:99–106

    PubMed  CAS  Google Scholar 

  227. Tubiana M, Henry-Amar M, Burgers MV, Van der Werf, Messing B, Hayat M (1984a) Prognostic significance of ESR in clinical stages I and II Hodgkin’s disease. J Clin Oncol 2:194–200

    PubMed  CAS  Google Scholar 

  228. Tubiana M, Henry-Amar M, Hayat M, Burgers M, Qasim M, Somers R, Sizoo W, Van der Schueren E (1984b) Prognostic significance of the number of involved areas in the early stages of Hodgkin’s disease. Cancer 54:885–894

    PubMed  CAS  Google Scholar 

  229. Tubiana M, Henry-Amar M, van der Werf-Messing B, Henry J, Abbatucci J, Burgers M, Hayat M, Somers R, Laugier A, Carde P (1985) A multivariate analysis of prognostic factors in early stage Hodgkin’s disease. Int J Radiat Oncol Bioi Phys 11:23–30

    CAS  Google Scholar 

  230. Tubiana M, Henry-Amar M, Carde P, Burgers JMV, Hayat M, Van der Schueren E, Noordijk EM, Tanguy A, Meerwaldt JH, Thomas J, De Pauw B, Monconduit M, Cosset JM, Somers R (1989) Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin’s disease. The EORTC lymphoma group controlled clinical trials: 1964–1987. Blood 73:47–56

    PubMed  CAS  Google Scholar 

  231. gestrichen

    Google Scholar 

  232. Tucker MA, Misfeldt D, Coleman N, Clark WH, Rosenberg SA (1985) Cutaneous malignant melanoma after Hodgkin’s disease. Ann Intern Med 102:37–41

    PubMed  CAS  Google Scholar 

  233. Tucker MA, Meadows AT, Boice JD, Stovall M, Oberlin O, Stone BJ, Birch J, Voute PA, Hoover RN, Fraumeni JF (1987a) Leukemia after therapy with alkyl ating agents for childhood cancer. J Nat Cancer Inst 78:459–464

    PubMed  CAS  Google Scholar 

  234. Tucker MA, D’Angio GJ, Boici JD, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, Hoover RN, Fraumeni JF (1987b) Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588–593

    PubMed  CAS  Google Scholar 

  235. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin’s disease. N Engl J Med 318:76–81

    PubMed  CAS  Google Scholar 

  236. Twomey JJ, Laughter AH, Rice L, Ford R (1980) Spectrum of immunodeficiences with Hodgkin’s disease. J Clin Invest 66:629–637

    PubMed  CAS  Google Scholar 

  237. Van Leeuwen FE, Somers R, Hart AAM (1987) Splenectomy in Hodgkin’s disease and second leukaemias. Lancet 2:210–211

    PubMed  Google Scholar 

  238. Waddell CC, Cimo PL (1979) Idipathic thrombocytopenia purpura occurring in Hodgkin’s disease after splenectomy: Report of two cases and review of the literature. Am J Haematol 7:381–387

    CAS  Google Scholar 

  239. Weiss LM, Strickler JG, Hu E, Warnke RA, Sklar J (1986) Immunoglobulin gene rearrangements in Hodgkin’s disease. Hum Pathol 17:1009–1014

    PubMed  CAS  Google Scholar 

  240. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J (1987) Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol 129:86–91

    PubMed  CAS  Google Scholar 

  241. Weiss LM, Movahed LA, Warnke SA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502–506

    PubMed  CAS  Google Scholar 

  242. Weitzman SA et al (1977) Impaired humoral immunity in treated Hodgkin’s disease. N Engl J Med 297: 245

    PubMed  CAS  Google Scholar 

  243. Whitehead E et al (1982) The effects of Hodgkin’s disease and combination chemotherapy on gonadal function in the adult male. Cancer 49:418

    PubMed  CAS  Google Scholar 

  244. Wieczorek R, Burke JS, Knowles DM (1985) Leu-Ml antigen expression in T-cellneoplasia. Am J Pathol 121: 374–380

    PubMed  CAS  Google Scholar 

  245. Wijlhuizen TJ, Vrints LW, Jairam R, Breed WPM, Wijnen JTM, Bosch U, Crommelin MA, van Dam FE, De Koning J, Verhagen-Teulings M (1989) Grades of nodular sclerosis (NSI-NSII) in Hodgkin’s disease. Cancer 63:1150–1153

    PubMed  CAS  Google Scholar 

  246. Young RC, Corder MP, Haynes HA, DeVita VT (1972) Delayed hypersensitivity in Hodgkin’s disease: A study of 103 untreated patients. Am J Med 52:62–72

    Google Scholar 

  247. Zaccaria A et al (1983) Acute nonlymphocytic leukemias and dysmyelopoietic syndromas in patients treated for Hodgkin’s lymphomas. Cancer Genet Cytogenet 9:217

    PubMed  CAS  Google Scholar 

  248. Zaloga GP, Eil C, Medberry CA (1985) Humoral hypercalcemia in Hodgkin’s disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption. Arch Intern Med 145:155–157

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Greil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Fasching
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Hämatologie und Onkologie, Universitätsklinik für Innere Medizin, Anichstraße 35, A-6020, Innsbruck, Austria

    Heinz Huber

  2. II. Med. Universitätsklinik und Poliklinik, Chemnitzstraße 33, D-2300, Kiel 1, Germany

    Helmut Löffler

  3. Universitätsklinik für Innere Medizin, Anichstraße 35, A-6020, Austria, Österreich

    Dorothea Pastner

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Huber, H., Greil, R., Fasching, B., Diehl, V. (1992). M. Hodgkin. In: Huber, H., Löffler, H., Pastner, D. (eds) Diagnostische Hämatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76860-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76860-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76861-3

  • Online ISBN: 978-3-642-76860-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation